Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile
Tjeerd Barf(FF Pharma (Netherlands)), Allard Kaptein
Cited by 366
Related Papers
No related papers found
Powered by citation graph analysis